Holen Sie sich die Stockscreener-App
44.81
1.08%
-0.49
Handel nachbörslich:
44.75
-0.06
-0.13%
Schlusskurs vom Vortag:
$45.30
Offen:
$44.7
24-Stunden-Volumen:
13.51M
Relative Volume:
0.67
Marktkapitalisierung:
$66.60B
Einnahmen:
$20.62B
Nettoeinkommen (Verlust:
$3.56B
KGV:
18.79
EPS:
2.3847
Netto-Cashflow:
$3.48B
1W Leistung:
+4.06%
1M Leistung:
-7.99%
6M Leistung:
-54.45%
1J Leistung:
-56.24%
1-Tages-Spanne:
$44.01
$44.98
1-Wochen-Bereich:
$43.45
$46.37
52-Wochen-Spanne:
$42.25
$109.50
Boston Scientific Corp Stock (BSX) Company Profile
Firmenname
Boston Scientific Corp
Sektor
Branche
Telefon
508-683-4000
Adresse
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, SYK, MDT, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
44.81 | 67.33B | 20.62B | 3.56B | 3.48B | 2.3847 |
ABT
Abbott Laboratories
|
95.18 | 166.94B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
326.85 | 126.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
82.01 | 107.31B | 36.36B | 4.84B | 5.43B | 3.7212 |
EW
Edwards Lifesciences Corp
|
93.64 | 54.60B | 6.30B | 1.07B | 1.09B | 1.8406 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-30 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2025-10-03 | Herabstufung | Erste Group | Buy → Hold |
| 2025-09-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-06-16 | Eingeleitet | Leerink Partners | Outperform |
| 2025-04-16 | Hochstufung | Needham | Hold → Buy |
| 2025-01-10 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-10-18 | Herabstufung | Needham | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2024-02-01 | Hochstufung | Mizuho | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-06-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-12-22 | Eingeleitet | Mizuho | Neutral |
| 2022-12-20 | Fortgesetzt | Citigroup | Buy |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-05-27 | Hochstufung | Needham | Hold → Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-05-26 | Herabstufung | Needham | Buy → Hold |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-17 | Eingeleitet | Truist | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-04-22 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Hochstufung | Goldman | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Neutral |
| 2020-02-06 | Fortgesetzt | BTIG Research | Buy |
| 2019-12-30 | Bestätigt | Cowen | Outperform |
| 2019-12-19 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-09-05 | Fortgesetzt | JP Morgan | Overweight |
| 2019-09-03 | Fortgesetzt | Barclays | Overweight |
| 2019-05-13 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Eingeleitet | UBS | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-10-02 | Bestätigt | Morgan Stanley | Overweight |
| 2018-09-07 | Bestätigt | Needham | Strong Buy |
| 2018-09-04 | Hochstufung | Jefferies | Hold → Buy |
| 2018-07-06 | Bestätigt | Needham | Strong Buy |
| 2018-06-27 | Eingeleitet | Bernstein | Outperform |
| 2018-04-26 | Bestätigt | Needham | Strong Buy |
Alle ansehen
Boston Scientific Corp Aktie (BSX) Neueste Nachrichten
Boston Scientific (NYSE:BSX) Climbs As Cardiology Demand Expands - Kalkine Media
BSX Maintained by Needham -- Price Target Lowered to $57.00 - GuruFocus
Needham cuts Boston Scientific stock price target on WATCHMAN sales By Investing.com - Investing.com Canada
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Boston Scientific focuses on cardiovascular innovation as medical device demand grows - AD HOC NEWS
Boston Scientific (BSX) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Boston Scientific Corp. stock underperforms Monday when compared to competitors - MarketWatch
Is Boston Scientific (BSX) Still One of the Best Stocks to Invest In After Jefferies Slashed Its Target? - Yahoo Finance
BSXBoston Scientific Corp Volatility & Greeks - Finviz
Boston Scientific (BSX) Stock Could Be A Bargain After A 57% Slump - Yahoo Finance
Boston Scientific: The Time Has Come To Catch This Falling Knife (NYSE:BSX) - Seeking Alpha
Munro Partners's Boston Scientific Corp(BSX) Holding History - GuruFocus
Boston Scientific Corp. highlights minimally invasive care. Long-term demand supports its medical te - AD HOC NEWS
Boston Scientific Corp (NYSE:BSX) Offers Strong Value with High Profitability and Solid Growth - ChartMill
symbol__ Stock Quote Price and Forecast - CNN
Penumbra shareholders approve merger with Boston Scientific - Investing.com
Boston Scientific stock hits 52-week low at 61.23 USD - Investing.com
Boston Scientific Corp (BSX) Stock Up 4.8% and Still Undervalued -- GF Score: 74/100 - GuruFocus
Form 4 Boston Scientific Corp For: 2 July By Investing.com - Investing.com India
Boston Scientific (BSX) CFO reports RSU conversion and tax-withheld shares - Stock Titan
Boston Scientific’s Quarterly Earnings Preview: What You Need to Know - Barchart.com
Stifel Cuts PT on Boston Scientific Corporation (BSX)- Here’s Why - Insider Monkey
List of 57 Acquisitions by Boston Scientific (Jul 2026) - Tracxn
Boston Scientific (BSX) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance
Boston Scientific Corp. stock outperforms competitors despite losses on the day - MarketWatch
Boston Scientific Stock (BSX) Opinions on Recent Analyst Downgrades - Quiver Quantitative
Boston Scientific adjusts growth outlook as stock struggles. Guidance cuts weigh on sentiment - AD HOC NEWS
Boston Scientific (BSX) Invests $1.5B in MiRus for Equity Stake and TAVR Acquisition Option - Insider Monkey
Boston Scientific stock hits 52-week low at 43.87 USD By Investing.com - Investing.com South Africa
Boston Scientific stock hits 52-week low at 43.87 USD - Investing.com
Boston Scientific strategy focus, shares hold in S&P 500 healthcare group - AD HOC NEWS
The WATCHMAN FLX Pro from Boston Scientific Corp.left atrial appendage closure gets smoother in c - Ad-hoc-news.de
World Implantable Neurostimulation DevicesMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
WAYCROSS PARTNERS, LLC's Boston Scientific Corp(BSX) Holding History - GuruFocus
Is Boston Scientific (BSX) One of the Best Low Volatility Stocks to Buy Under $50? - Insider Monkey
Brain Implants Market Size to Reach USD 18.39 Billion by 2035, Growing at 9.99% CAGR | SNS Insider - GlobeNewswire Inc.
Boston Scientific Corp Investor Event at the Scientific Session of the American College of Cardiology Transcript - GuruFocus
Volkswagen Plans to Cut Up to 100,000 Jobs and Close 4 German Plants, European Auto Industry Faces Historic Restructuring - TradingKey
Boston Scientific Options Spot-On: On June 25th, 67,433 Contracts Were Traded, With 779.57K Open Interest - Moomoo
Boston Scientific (NYSE:BSX) Gains Fresh Market Attention - Kalkine Media
BSX Maintained by Stifel -- Price Target Lowered to $65.00 - GuruFocus
TD Cowen Maintains a Buy Rating on Boston Scientific (BSX) - Insider Monkey
Stifel Adjusts Price Target on Boston Scientific to $65 From $75, Maintains Buy Rating - marketscreener.com
Japan, South Korea Stocks Rally; Nikkei 225 Nears Previous High, Kospi Rises Over 5%, Memory Giants SK Hynix and Kioxia Soar Over 12% - TradingKey
Boston Scientific (BSX) Registers a Bigger Fall Than the Market: Important Facts to Note - sharewise.com
Micron Q3 Data Center Revenue Grows Over Sevenfold YoY; Shares Jump Over 14% Post-Market, Memory Supply Shortage to Last Beyond 2027 - TradingKey
How a Targeted Valve Recall and Watchman Questions at Boston Scientific (BSX) Have Changed Its Investment Story - Yahoo Finance
Boston Scientific (BSX) Recalls Orca Valves Nationwide After Device Malfunction - Yahoo Finance
BSX Maintains Buy Rating by Jefferies -- Price Target Lowered to $67.00 - GuruFocus
BSX Stock | Boston Scientific Corp Q1 2025 Earnings Call Bear Attack (FjRIiYMEgO) - Mshale
Boston Scientific (BSX) Faces 52.54% Decline Amid Weak Momentum Grades - GuruFocus
Finanzdaten der Boston Scientific Corp-Aktie (BSX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.24%
0.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):